Nur zu Informationszwecken. Lassen Sie sich immer von medizinischem Fachpersonal beraten.
MPMediPriceHubArzneimittelpreise im Überblick
PRODUCT INFORMATION

Lenvima 10mg capsulas(lenvatinib) (lenvatinib mesylate)

lenvatinib mesylate

Lenvima 10mg capsulas(lenvatinib) (lenvatinib mesylate)
Reference priceEUR €577.50Original source price: INR 52,500.00. Converted estimates are available by currency selection.
BrandLenvima Capsules
ManufacturerEisai Co.Ltd
Prescription requiredYes

Description

Lenvima 10mg capsulas(lenvatinib) (lenvatinib mesylate) is a medicine catalog record in the MediPriceHub database. Active ingredient: lenvatinib mesylate. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Eisai Co.Ltd. Therapeutic category: Medicine Library > Oncology Medicines > Hepatocellular Carcinoma. Pack information: 10 / 30. Origin country or market: Spain. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.

Benefits

Lenvatinib is a tyrosine kinase inhibitor used for selected cancers including differentiated thyroid cancer, hepatocellular carcinoma, renal cell carcinoma in combination regimens, and endometrial carcinoma in combination with pembrolizumab where approved.

How to Use

Use lenvatinib mesylate under the supervision of a qualified healthcare professional. Use it only according to the approved label and the instructions of a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.

Specification

Active ingredient: lenvatinib mesylate. Pack size: 10 / 30. Pack unit: box. Manufacturer: Eisai Co.Ltd. Origin country: Spain. Source category: Medicine Library > Oncology Medicines > Hepatocellular Carcinoma. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.

Side Effects

Laboratorio titular: EISAI GMBH. Indicaciones: Snomed CT:

Diese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.